Oncolytics Biotech Stock Price on November 29, 2024
| ONCY Stock | USD 0.93 0.02 2.11% |
Below is the normalized historical share price chart for Oncolytics Biotech extending back to October 05, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Oncolytics Biotech stands at 0.93, as last reported on the 29th of November, with the highest price reaching 0.97 and the lowest price hitting 0.91 during the day.
If you're considering investing in Oncolytics Stock, it is important to understand the factors that can impact its price. At this stage we consider Oncolytics Stock to be abnormally volatile. Oncolytics Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.0195, which implies the firm had a 0.0195% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Oncolytics Biotech, which you can use to evaluate the volatility of the company. Please check Oncolytics Biotech's Coefficient Of Variation of 7489.51, risk adjusted performance of 0.0188, and Semi Deviation of 3.53 to confirm if the risk estimate we provide is consistent with the expected return of 0.11%.
At this time, Oncolytics Biotech's Common Stock Shares Outstanding is fairly stable compared to the past year. Common Stock Total Equity is likely to rise to about 430.9 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 17.8 M in 2024. . At this time, Oncolytics Biotech's Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.96 in 2024, whereas Price To Sales Ratio is likely to drop 66.83 in 2024. Oncolytics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of November 1999 | 200 Day MA 1.0559 | 50 Day MA 1.0896 | Beta 1.506 |
Oncolytics |
Sharpe Ratio = 0.0195
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | ONCY | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.6 actual daily | 49 51% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Oncolytics Biotech is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oncolytics Biotech by adding it to a well-diversified portfolio.
Price Book 11.1236 | Book Value 0.37 | Enterprise Value 58.1 M | Enterprise Value Ebitda (1.79) | Shares Float 73.8 M |
Related Headline
Day One Headline on 29th of November 2024
Disposition of 6062 shares by Blackman Samuel C. of Day One ... by Blackman Samuel C.
Filed transaction by Day One Biopharmaceuticals Officer Head Of Rd. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Oncolytics Biotech Valuation on November 29, 2024
It is possible to determine the worth of Oncolytics Biotech on a given historical date. On November 29, 2024 Oncolytics was worth 0.96 at the beginning of the trading date compared to the closed value of 0.93. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oncolytics Biotech stock. Still, in general, we apply an absolute valuation method to find Oncolytics Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oncolytics Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oncolytics Biotech's related companies.
| Open | High | Low | Close | Volume | |
| 0.96 | 0.97 | 0.91 | 0.93 | 153,977 | |
11/29/2024 | 0.96 | 0.97 | 0.91 | 0.93 | 0.00 |
| Backtest Oncolytics Biotech | | | Oncolytics Biotech History | | | Oncolytics Biotech Valuation | Previous |
Oncolytics Biotech Trading Date Momentum on November 29, 2024
| On November 29 2024 Oncolytics Biotech was traded for 0.93 at the closing time. The top price for the day was 0.97 and the lowest listed price was 0.91 . There was no trading activity during the period 0.0. Lack of trading volume on November 29, 2024 did not cause price change. The trading delta at closing time against the current closing price is 3.23% . |
Oncolytics Biotech Fundamentals Correlations and Trends
By evaluating Oncolytics Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oncolytics Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oncolytics financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Oncolytics Biotech Stock history
Oncolytics Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oncolytics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oncolytics Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oncolytics Biotech stock prices may prove useful in developing a viable investing in Oncolytics Biotech
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 67.6 M | 71 M | |
| Net Loss | -22.4 M | -21.2 M |
Oncolytics Biotech Quarterly Net Working Capital |
|
Oncolytics Biotech Stock Technical Analysis
Oncolytics Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Oncolytics Biotech Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Oncolytics Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Oncolytics Biotech November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Oncolytics Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncolytics Biotech shares will generate the highest return on investment. By undertsting and applying Oncolytics Biotech stock market strength indicators, traders can identify Oncolytics Biotech entry and exit signals to maximize returns
Oncolytics Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Oncolytics Biotech's price direction in advance. Along with the technical and fundamental analysis of Oncolytics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oncolytics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0188 | |||
| Jensen Alpha | 0.1365 | |||
| Total Risk Alpha | (0.76) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.1) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Oncolytics Stock Analysis
When running Oncolytics Biotech's price analysis, check to measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.